SEC Form 4 research
| Issuer | FENNEC PHARMACEUTICALS INC. |
|---|---|
| Tickers | ADH, AHX, ADHXF, FENC |
| Reporting owners | 44 |
| Officers and directors | 6 |
| Last public filing | 2026-11-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-02 | 2026-10-31 | Evans Terry L | A | 168 | $0 | Not reported |
| 2026-11-02 | 2026-10-31 | Sayad Pierre Sargis | A | 168 | $0 | Not reported |
| 2026-11-02 | 2026-10-31 | Hackman Jeffrey S. | A | 1,159 | $0 | Not reported |
| 2026-11-02 | 2026-10-31 | Cioffi Christiana Marie | A | 156 | $0 | Not reported |
| 2026-11-02 | 2026-10-31 | Andrade Robert | A | 1,703 | $0 | Not reported |
| 2026-10-13 | 2026-10-12 | Sayad Pierre Sargis | A | 3,846 | $5.53 | Not reported |
| 2026-10-13 | 2026-10-12 | Hackman Jeffrey S. | A | 2,224 | $5.53 | Not reported |
| 2026-10-13 | 2026-10-12 | Evans Terry L | A | 2,326 | $5.53 | Not reported |
| 2026-10-13 | 2026-10-12 | Cioffi Christiana Marie | A | 3,946 | $5.53 | Not reported |
| 2026-10-13 | 2026-10-12 | Andrade Robert | A | 3,846 | $5.53 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.